Law360, New York (January 11, 2007, 12:00 AM EST) -- The U.S. Food and Drug Administration revealed Thursday that it intends to ask Congress to authorize an $87.4 million increase to its prescription drug user fee program in order to upgrade its drug safety program and increase the development of new medications in the coming years.
Prescription drug user fee programs, which require drug and medical technology firms to pay certain fees to the FDA, have to be reauthorized by Congress every five years. The current version is set to expire September 30, 2007.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.